Marc Beer: A Leader of Men

Marc Beer is one of the best executives in the game. For more than 25 years he’s been a manager, a director and a CEO occupying executive positions in different capacities. He’s currently the CEO and co-founder of Renovia Inc. A company specialized in women’s healthcare and keeping them out of pelvic surgery. Before his current position, he was the chief executive officer of ViaCell, a firm that develops and preserves blood stem cells of the umbilical cord. In other capacities, he has served as the chairman of compensation committees like the Good Start Genetics committee and he is also a member of the Minerva neurosciences committee and a member of the business advisory of the Miami University. Hs inspiration for the new venture started when a gynecologist of over 70 years old contacted him to suggest the solution to pelvic surgeries. This made an impact on Marc Beer because it wasn’t just coming from anyone, but a veteran in the healthcare system. Ever since then, he has made it a priority to improve on pelvic health care. Being an entrepreneur is not easy, but Mark beer finds different ways to cope with the challenges of day-to-day operations. To foster productivity, he makes sure that is free enough to take on challenges and gain the right talent. He stresses that being a CEO is not to do everything in the company but obtain the target and get the right people to do the job. Progress and development of a company is solely based on the people that carry out operation and Marc understands that principle. The tactic is to obtain individuals focused on mid-term and long-term goals of the company, balancing two scales at the same time. To bring ideas to life, you make sure all the principal areas are covered. Areas like the illegal, financial, commercial and technical departments. Without progress in this area, it is far too difficult to make ideas a reality. According to him, one dimensional thinking and products are bound to crash and he’s not in the business of failure. Marc Beer is excited by companies that change the perception of what is normal and try to bring ideas to life, in a world where conventional thinking is the norm. To truly breakthrough, one has to be non-conventional thinker and that takes multi-layered levels of thinking to drive. He makes examples of Tesla in the car industry and Airbnb in the hotel industry. His company is also on the verge of changing the norm in healthcare. With the dream of making this a reality, she hopes that the next decade or two, breakthroughs will be made in digital healthcare that will save lives and generate even more money for his company. Learn more:

Marc Beer: A Prominent Figure in the Healthcare Industry Who is Bringing Change


Marc Beer has received the honor of being appointed to the Board of LumeNXT as Chairman. LumeNXT announced the news early this year. LumeNXT is a prominent company which develops proprietary surgical illumination products aimed at streamlining minimally invasive surgeries. Mr. Beer has more than 25 years of experience in the healthcare. Specifically, his development and commercialization experience is focused on pharmaceuticals, biotechnology, devices, as well as diagnostics.


Marc Beer was featured saying that he was grateful to be part of a team of successful surgeons as well as engineers who have worked to advance the field of surgical illumination leveraging the LumeNXT proprietary technology. The technology is important when performing surgery safely. He believes that people will continue realization the importance of LumeNXT platform with time as more surgeries continue to be performed. Surgeons who specialize in targeted illumination have realized that the technology enhances flexibility, precision, and visualization during operations as compared to if they would leverage traditional techniques.


The LumeNXT’s advanced illumination platform reduces heat to improve low-cost disposable options, surgical precision, and safety leveraging enhanced visualization. According to Paul Rhyne, the Co-Founder of LumeNXT, Marc Beer is a successful entrepreneur who has achieved high level of success in many startup companies that he guided through their growth. He also added that his extensive experience in establishing companies as well as helping them to grow through global commercial rollout as well as the path to profitability will be of a high value to the company as it grows.


Marc Beer is the Chairman and CEO of Renovia Inc., a company he founded with a mission to develop innovative therapeutic and diagnostic products for women living with pelvic floor disorders across the world. Prior to founding Renovia, Marc Beer held many leadership capacities in the field of biopharmaceutical where he led efforts to address rare disease globally. Some of Marc Beer’s former positions include Founding Chairman of Good Start Genetics, Inc.’s board of directors, previous CEO of ViaCell, member of board of directors of Erytech Pharma, Global Marketing Vice President at Genzyme as well as a number of positions carrying out sales and marketing roles at Abbot Laboratories.


The healthcare entrepreneur and investor was a member of the Mass Life Science Board of the Commonwealth of Massachusetts. He also spent some years at the Biotechnology Industry Organization (BIO) Emerging Companies Section Governing Board. Now at Renovia, he has been instrumental in the growth of the company raising millions of dollars to fund the development of therapeutic and diagnostic products to treat pelvic floor disorders in women. For instance, he raised $42 million for the women’s health startup. The money went toward developing as well as testing four more new therapeutic and diagnostic products. Learn more:

Carsten Thiel: The Value Of Pharmaceutics And Technology


A pharmaceutical & biopharmaceutical expert known as Carsten Thiel knows exactly how to turn his own brilliant ideas into reality by deeply understanding the potential and positive effects of having a team that is motivated and devoted to their work.

Carsten Thiel is an expert in the world of biotechnology. The CEO of Westlake Village Biopartners believes that humanity is headed towards the Golden Age of Biotechnology.

Carsten Thiel makes it a habit to encourage his team members and seeing their efforts. Having a professional career and earning a leadership position made him realize how he could be influential when it comes to medical marketing and market assessment.

Thiel is used to leading a team of employees, researchers, different individuals, and he learned that the most effective way of bringing ideas into life, achieving loyalty and long-term respect is through a collaborative effort. He noticed how every member of his team are passionate about their role in the company which is why he listens to all of their ideas, all concerns, and takes every opinion into consideration.

An article from IdeaMensch entitled: “Carsten Thiel: Pharmaceutical & Biopharmaceutical Expert”, Thiel shared how he started his foray into the innovative realm of pharmaceuticals and further expressed his views about the “Golden Age of Biotechnology”.

Carsten Thiel grew up in a family of medical doctors and he naturally felt the inclination to follow the footsteps of his own parents. During his adolescent years, Thiel was very engaged and interested in biology, science, and learning about medicine. According to Thiel, he could still remember the moment where he realized that becoming who he is now is what he really wants. He was very interested in how the DNA works and how it is accountable for the existence of humans. He always knew that he wanted to devote his time and his life by being a pharmaceutical expert. Find Additional Information Here.

In addition to this, Thiel has always been impressed by how technology advances and evolves. He uses advancements in technology as a method to assist patients and provide them a better service and health care. Thiel is very excited and positive of the future of medicine because of the rapid growth of technology.


Find more info about Thiel on

Carsten Thiel And His Contribution To Healthcare

For many years, Carsten Thiel has been researching on various topics relating to medicine. He is the brain behind the development of some of the most effective products in the markets today. Thiel’s love for biotechnology is one of the things that have propelled him to the top. Looking at some of the products that he has formulated, you will notice that he is focused to coming up with therapies that help people to overcome the emerging challenges in the medical world.


Impactful medical products

What Carsten Thiel believes in is the establishment of products that will have a major impact in the medical industry. He was to come up with solutions that manage the most complex situations such as surgery. Because of this, he has been combining technology with medicine to come up with these solutions. Read This Article for additional information

For instance, he helped to launch medical therapies such as Prolia and Neulasta. These are products that changed the way people treated several diseases and therefore, he had made his mark as an authority in this industry.


Solutions to the latest problems

Another thing that shows that Carsten Thiel has made enormous contributions to the healthcare industry is his eye for the latest challenges. Looking at his latest products, you will notice that he is focusing on weight loss. He wants people to enjoy better way of managing weight loss. While launching the products, he said that weight loss had become a global problem and therefore, there was need of effective medicines to tackle it.

When Carsten Thiel was born in Berlin, Germany, the country was divided between the east and the west. This affected his education and so, when it was time to join the University, he chose to move to the University of Bristol. This is one of the biggest universities in the UK, and it is where he got his education. He later joined other universities and got his PhD.


Visit his page on


“Marc Beer : Renovia Is Trying To Improve The Life Quality Of Women “

Today, with the development of modern medicine, most diseases are treatable. The important thing is to detect them in time. Joined together, technology and modern have mixed their capacities so that today it’s much easier to respond quickly in order to save our health. The early diagnostics sometimes can be of great importance when especially when we are dealing with cancer-related diseases.


Today, modern diagnostic methods are more available, and so they are more accessible to those in need. Technological and medical and innovation are truly a major step in diagnosing and treating various diseases.


Although we are living in the information era, we’re still pretty uninformed about women pelvic floor diseases. That’s why we could say that education joined with modern diagnostic is of major importance in order to effectively prevent and treat this highly spread disease.


The Mission Of Renovia Inc

Renovia Inc. is the company headed by Marc Beer the CEO. This company has focused on making new products which are directed to solving problems connected to women pelvic floor.


This medical-tech company is situated in Boston where they are working on the development of diagnostic performing. These innovations are used for therapy purpose in urinary incontinence and pelvic floor disorders. Most researchers agree with the fact that this disorder is widely spread in women. To be more concrete, it affects more than 250 million women worldwide.


Investors Of Renovia Inc.

The first presented medical product of Renovia Inc. was the Leva, – approved officially by the FDA in 2018. Afterward, Renovia has attracted plenty of investors, among them The Longwood Fund. The Longwood Fund is an investment company that’s highly pointing to health care issues. They invested in Renovia, joining two other investment enterprises – Ascension Ventures from Missouri and Perceptive Advisors from New York. The funds will be invested in developing and testing of four different diagnostic devices. That’s also including the Leva devices of the new generation.


Marc Beer CEO of Renovia Inc. is extremely satisfied with the support that the company has received from some of the leading investors. Marc Beer claims that this is the product of good cooperation. As he said, Renovia and company’s investors are sharing the exact same vision of future healthcare and prevention matters. Together, they hope they will manage to improve the treatment and the life quality for thousands of women who are suffering from pelvic floor disorder.


Innovations Of Renovia Inc.

Marc Beer recently revealed facts about combining the digital health platform and innovative sensor technology. This combination in diagnostics will give some very valuable information regarding the medical procedure, new treatment possibilities, and a general understanding and education on the subject of the pelvic floor disorder. However, Renovia Inc. hasn’t made its official statement considering investments and the new lines of their products.


Marc Beer’s business engagement with Renovia Inc. dates from 2015.


Before he becomes the CEO of Renovia Inc. he was working in other medical companies. Marc Beer brought to Renovia more than 25 years of his wide experience in biotechnological developing, as well as in pharmacy. Marc Beer was one who closed a chain of financing with some of the leading capital funds. Learn more:


Carsten Thiel And Biotechnology’s Golden Age


Humanity is on the cusp of a golden age of biotechnology, and it is entirely possible that we will all soon be leading much longer lives virtually free of disease. Just as the world has been through the space age and the computer age, soon we will be living in the biotechnology age.

The speed of advancement in biotechnology is now exponential; a tipping point has been reached, and as biotechnology expert Carsten Thiel and others explains, there are three main reasons for this.

Progress in Technology

Sequencing the human genome has gotten dramatically cheaper since the process was introduced in the 1990’s, and this is because of the increasing speed and storage capacities of computers. Today, experts like Carsten Thiel can use the human genome itself in their research; whereas, in the past, it was necessary to look at mice.

Better comprehension of human biology

Improved technology leads to improved understanding. Carsten Thiel and other biotechnology experts now see biology more in terms of engineering than ever before.

Carsten Thiel has a Ph.D and was the CEO of Abeona Therapeutics Inc. This is a biopharmaceutical company for clinical-stages that mainly develops gene and cell therapies for genetic diseases that are rare and life-threatening. It is a company that is a major part of the golden age of biotechnology that Carsten Thiel is very much a part of.

Just as in the 1990’s when the target biology revolution made it possible to develop drugs to treat AIDS and other diseases, machine learning, automation and the quantification of biology will likely lead to breakthroughs in medicine in the near future. Go To This Page for additional information.

More tools

Gene therapies, nucleic acids and non-particle delivery systems are just some of the new modalities researchers and doctors are now using to research disease. In short, the future is bright for medicine.


See also:


“Marc Beer Launching a New Product For Pelvic Floor Disorders “

A large number of women in the world face health problems especially their reproductive health. Research shows 250 million women in the world suffer from pelvic floor disorders and urinary incontinence. These conditions compromise the health of the women who are very important individuals in the contribution of the world’s economy. Renovia Inc., a Boston based company manufactures pharmaceuticals and therapeutic products which help in the treatment of the pelvic floor disorders and urinary incontinence.


The founder of the company is Mr. Marc Beer who founded the company in the year 2015. Marc has over 25 years experience in commercializing and developing the pharmaceutical and biotechnology industries. Renovia Inc. is a renowned pharmaceutical company in the United States and has produced one product from the management of the conditions known as Leva. The product was approved by FDA, this shows that the company’s products are recommendable one for use. Prior to founding the company marc beer used to be the chief executive officer at Aegerion pharmaceutical.


Marc Beer is an alumnus of Miami University in Ohio and graduated with a bachelor’s degree in business administration. He is a reputable professional who has worked with many companies and his work was an excellent one. Marc has served as the vice president of Viacell Inc. as well as the company’s chief executive officer. He has also worked with Sanofi Pharmaceutical companies as the vice president of global marketing. Marc was also the senior manager and vice president of Genzyme Corporation. He has also worked with Biostar as sales and marketing president.


Marc Beer was a consultant and a board member of Private Life Companies between 2007 and 2010. He was also an administrative and strategic consultant at OVAS (Ova Science) Company. He has served as the chairman of Cytopherx and Good Start Genetic companies.


Last year Marc Beer launched their series B project of manufacturing new products for treating pelvic floor disorders. They also improved the initial product, Leva and introduced four new pharmaceutical and diagnostic drugs for the disorders. The project cost was $42 million and they received support from other investment companies to make it a successful project. The company also created a digital health platform which will help clients be informed about new treatment options and get a better understanding of the pelvic floor disorders. This project will definitely help a lot of women worldwide. Learn more: